Andrew Quesada Tan1,2, Stella Barth2,3, Randy D Trumbower1,2. 1. Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA. USA. 2. Spaulding Rehabilitation Hospital, Boston MA. 3. Harvard University, Cambridge MA.
Abstract
PURPOSE OF REVIEW: The reacquisition and preservation of walking ability are highly valued goals in spinal cord injury (SCI) rehabilitation. Recurrent episodes of breathing low oxygen (i.e., acute intermittent hypoxia, AIH) is a potential therapy to promote walking recovery after incomplete SCI via endogenous mechanisms of neuroplasticity. Here, we report on the progress of AIH, alone or paired with other treatments, on walking recovery in persons with incomplete SCI. We evaluate the evidence of AIH as a therapy ready for clinical and home use and the real and perceived challenges that may interfere with this possibility. RECENT FINDINGS: Repetitive AIH is a safe and an efficacious treatment to enhance strength, walking speed and endurance, as well as, dynamic balance in persons with chronic, incomplete SCI. SUMMARY: The potential for AIH as a treatment for SCI remains high, but further research is necessary to understand treatment targets and effectiveness in a large cohort of persons with SCI.
PURPOSE OF REVIEW: The reacquisition and preservation of walking ability are highly valued goals in spinal cord injury (SCI) rehabilitation. Recurrent episodes of breathing low oxygen (i.e., acute intermittent hypoxia, AIH) is a potential therapy to promote walking recovery after incomplete SCI via endogenous mechanisms of neuroplasticity. Here, we report on the progress of AIH, alone or paired with other treatments, on walking recovery in persons with incomplete SCI. We evaluate the evidence of AIH as a therapy ready for clinical and home use and the real and perceived challenges that may interfere with this possibility. RECENT FINDINGS: Repetitive AIH is a safe and an efficacious treatment to enhance strength, walking speed and endurance, as well as, dynamic balance in persons with chronic, incomplete SCI. SUMMARY: The potential for AIH as a treatment for SCI remains high, but further research is necessary to understand treatment targets and effectiveness in a large cohort of persons with SCI.
Authors: Heather B Hayes; Stacie A Chvatal; Margaret A French; Lena H Ting; Randy D Trumbower Journal: Clin Neurophysiol Date: 2014-02-14 Impact factor: 3.708
Authors: Brian K Kwon; Femke Streijger; Nader Fallah; Vanessa K Noonan; Lise M Bélanger; Leanna Ritchie; Scott J Paquette; Tamir Ailon; Michael C Boyd; John Street; Charles G Fisher; Marcel F Dvorak Journal: J Neurotrauma Date: 2016-08-15 Impact factor: 5.269
Authors: Martin Burtscher; Otmar Pachinger; Igor Ehrenbourg; Günther Mitterbauer; Martin Faulhaber; Reinhard Pühringer; Elena Tkatchouk Journal: Int J Cardiol Date: 2004-08 Impact factor: 4.164
Authors: Tracy L Baker-Herman; David D Fuller; Ryan W Bavis; Andrea G Zabka; Francis J Golder; Nicholas J Doperalski; Rebecca A Johnson; Jyoti J Watters; Gordon S Mitchell Journal: Nat Neurosci Date: 2003-12-14 Impact factor: 24.884
Authors: Nicole J Tester; David D Fuller; Jason S Fromm; Martina R Spiess; Andrea L Behrman; Jason H Mateika Journal: Am J Respir Crit Care Med Date: 2014-01-01 Impact factor: 21.405